Amikacin Prophylaxis and Risk Factors for Surgical Site Infection After Kidney Transplantation. Issue 3 (March 2015)

• Record Type: Journal Article
• Authors: Freire, Maristela P.; Antonopoulos, Ioannis M.; Piovesan, Affonso Celso; Moura, Maria L.; de Paula, Flávio Jota; Spadão, Fernanda; Guimarães, Thais; David-Neto, Elias; Nahas, William C.; Pierrotti, Ligia C.
• Is Part Of: Transplantation. Volume 99:Issue 3(2015)
• Publication Date: 2015-03
• Subjects: Transplantation of organs, tissues, etc -- Periodicals; Transplantation immunology -- Periodicals; 617.95
• DOI: 10.1097/TP.0000000000000381
• Languages: English
• ISSNs: 0041-1337

Abstract

Abstract : Background: Antibiotic prophylaxis plays a major role in preventing surgical site infections (SSIs). This study aimed to evaluate antibiotic prophylaxis in kidney transplantation and identify risk factors for SSIs. Methods: We evaluated all kidney transplantation recipients from January 2009 and December 2012. We excluded patients who died within the first 72 hr after transplantation, were undergoing simultaneous transplantation of another organ, or were below 12 years of age. The main outcome measure was SSI during the first 60 days after transplantation. Results: A total of 819 kidney transplants recipients were evaluated, 65% of whom received a deceased-donor kidney. The antibiotics used as prophylaxis included cephalosporin, in 576 (70%) cases, and amikacin, in 233 (28%). We identified SSIs in 106 cases (13%), the causative agent being identified in 72 (68%). Among the isolated bacteria, infections caused by extended-spectrum β-lactamase–producing Enterobacteriaceae predominated. Multivariate analysis revealed that the risk factors for post-kidney transplantation SSIs were deceased donor, thin ureters at kidney transplantation, antithymocyte globulin induction therapy, blood transfusion at the transplantation procedure, high body mass index, and diabetes mellitus. The only factor associated with a reduction in the incidence of SSIs was amikacin use as antibiotic prophylaxis. Factors associated with reduced graft survival were: intraoperative blood transfusions, reoperation, human leukocyte antigen mismatch, use of nonstandard immunosuppression therapy, deceased donor, post-kidney transplantation SSIs, and delayed graft function. Conclusion: Amikacin prophylaxis is a useful strategy for preventing SSIs. Abstract : Amikacin is superior to a cephalosporin for perioperative antibiotic prophylaxis for wound infections after renal transplantation. Supplemental digital content is available in the text.